Curing cancer with Cannabidiol?
- CANNABIS OIL, NEWS
- April 24, 2013
In a groundbreaking move, the Drug Enforcement Administration (DEA) is proposing regulations that would reclassify cannabis as medicine rather than an illicit drug. This potential shift to Schedule III classification could have far-reaching implications for both patients and researchers. While cannabis would still be available at state-authorized dispensaries, the reclassification could pave the way for
READ MOREA groundbreaking study from the University of Colorado Boulder has revealed that CBD-dominant cannabis products may be more effective at reducing anxiety than THC-dominant alternatives, without the potential side effects associated with THC.The research, published in the journal Cannabis and Cannabinoid Research, involved 300 participants and is the first randomized trial to examine how commercially available
READ MOREIn a significant legislative move, the North Carolina Senate has passed a bill to legalize medical marijuana, a measure that now faces an uncertain fate in the House. The bill, which includes stringent regulations on hemp-derived products, aims to provide relief to patients with specific medical conditions. Proponents argue it offers a compassionate solution for
READ MOREJune 2024 – Danish medical cannabis manufacturer Stenocare has announced the launch of a groundbreaking cannabis oil designed to enhance bioavailability. This new product aims to set a higher standard in the medical cannabis industry by improving the body’s absorption of active ingredients, thus increasing the oil’s therapeutic potential. The innovation is expected to address
READ MORE